Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 5, keine Gesamtzahl für „weeks“
Suchtreffer
Begriffe & Kennungen
Eviplera · 4.8 · Lipids At 96 weeks in the pooled Phase III C209 and C215 studies of treatment-naïve patients, in the rilpiviri
Eintrag öffnenEylea · 4.8 · A total of 1 808 patients treated with Eylea 114.3 mg/ml up to 96 weeks constituted the safety population in 4
Eintrag öffnenFasenra · 4.8 · In an open-label, uncontrolled pharmacokinetic and pharmacodynamic study of 48 weeks duration in a limited num
Eintrag öffnenFlebogamma DIF (previously Flebogammadif) · 4.5 · Immunoglobulin administration may impair for a period of at least 6 weeks and up to 3 months the efficacy of l
Eintrag öffnenFlebogamma DIF (previously Flebogammadif) · 4.5 · Immunoglobulin administration may impair for a period of at least 6 weeks and up to 3 months the efficacy of l
Eintrag öffnenForxiga · 4.8 · In an add-on to glimepiride study, at weeks 24 and 48, minor episodes of hypoglycaemia were reported more freq
Eintrag öffnenForxiga · 4.8 · In an add-on to metformin and a sulphonylurea study, up to 24 weeks, no episodes of major hypoglycaemia were r
Eintrag öffnenGenvoya · 4.8 · The safety of Genvoya was evaluated through 48 weeks in HIV-1 infected adolescent patients aged 12 to < 18 yea
Eintrag öffnenGliolan · 4.5 · Patients should not be exposed to any photosensitising agent up to 2 weeks after administration of Gliolan.
Eintrag öffnenHBVaxPro · 4.8 · Apnoea in very premature infants (born ≤ 28 weeks of gestation) (see section 4.4).
Eintrag öffnenHBVaxPro · 4.8 · Apnoea in very premature infants (born ≤ 28 weeks of gestation) (see section 4.4).
Eintrag öffnenHalaven · 4.8 · 8 307/404 (76.0%) and 1314/1559 (84.3%), respectively. The median duration of treatment was 12.0 weeks for sar
Eintrag öffnenHarvoni · 4.8 · Ledipasvir/sofosbuvir was administered for 12 weeks to 18 patients with genotype 1 CHC and severe renal impair
Eintrag öffnenHarvoni · 4.8 · Ledipasvir/sofosbuvir was administered for 12 weeks to 18 patients with genotype 1 CHC and severe renal impair
Eintrag öffnenHarvoni · 4.8 · The safety profile of ledipasvir/sofosbuvir with ribavirin for 12 or 24 weeks in adults with decompensated liv
Eintrag öffnenHarvoni · 4.8 · The safety profile of ledipasvir/sofosbuvir with ribavirin for 12 or 24 weeks in adults with decompensated liv
Eintrag öffnenHefiya · 4.8 · During the controlled portions of pivotal adalimumab studies in adults of at least 12 weeks in duration in pat
Eintrag öffnenHefiya · 4.8 · During the controlled portions of pivotal adalimumab studies in adults of at least 12 weeks in duration in pat
Eintrag öffnenHexyon · 4.8 · Hexyon has been administered to 143 preterm infants (born after a gestational period of 24 to 36 weeks) who re
Eintrag öffnenHexyon · 4.8 · Respiratory, thoracic and mediastinal disorders Apnoea in very premature infants (≤28 weeks of gestation) (see
Eintrag öffnen